Mark Schoenberg, Chief Medical Officer at UroGen Pharma Ltd. (URGN), sold 2,655 shares at $11.14 ($30K) on 2025-01-31, disclosed to the SEC on 2025-02-04.
Seasonal sale ($30k) by Chief Medical Officer — this insider has traded URGN in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.14 | 759 | $8K | 28.6% |
| 2 | $11.14 | 1,896 | $21K | 71.4% |
| Total | $11.14 avg | 2,655 | $30K | 100% |
| Filing → |
| URGN | SELL | 2026-07-10 | $400K | — | Filing → |
| URGN | SELL | 2026-06-24 | $350K | — | Filing → |
| URGN | SELL | 2026-06-09 | $143K | — | Filing → |